| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4000 | 2014 |
| Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589, 2018 | 1695 | 2018 |
| ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ... Multiple Sclerosis Journal 24 (2), 96-120, 2018 | 997 | 2018 |
| MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients MP Wattjes, À Rovira, D Miller, TA Yousry, MP Sormani, N De Stefano, ... Nature Reviews Neurology 11 (10), 597-607, 2015 | 567 | 2015 |
| Brain health: time matters in multiple sclerosis G Giovannoni, H Butzkueven, S Dhib-Jalbut, J Hobart, G Kobelt, G Pepper, ... Multiple sclerosis and related disorders 9, S5-S48, 2016 | 524 | 2016 |
| HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials A Gennari, MP Sormani, P Pronzato, M Puntoni, M Colozza, U Pfeffer, ... JNCI: Journal of the National Cancer Institute 100 (1), 14-20, 2008 | 505 | 2008 |
| MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process À Rovira, MP Wattjes, M Tintoré, C Tur, TA Yousry, MP Sormani, ... Nature Reviews Neurology 11 (8), 471-482, 2015 | 502 | 2015 |
| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 498 | 2021 |
| Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes N De Stefano, A Giorgio, M Battaglini, M Rovaris, MP Sormani, F Barkhof, ... Neurology 74 (23), 1868-1876, 2010 | 424 | 2010 |
| Classification criteria for autoinflammatory recurrent fevers M Gattorno, M Hofer, S Federici, F Vanoni, F Bovis, I Aksentijevich, ... Annals of the rheumatic diseases 78 (8), 1025-1032, 2019 | 409 | 2019 |
| Brain atrophy and lesion load predict long term disability in multiple sclerosis V Popescu, F Agosta, HE Hulst, IC Sluimer, DL Knol, MP Sormani, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1082-1091, 2013 | 403 | 2013 |
| Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes” M Filippi, M Rovaris, MA Rocca, MP Sormani, JS Wolinsky, G Comi, ... Neurology 57 (4), 731-733, 2001 | 372 | 2001 |
| Radiologically isolated syndrome: 5-year risk for an initial clinical event DT Okuda, A Siva, O Kantarci, M Inglese, I Katz, M Tutuncu, BM Keegan, ... PloS one 9 (3), e90509, 2014 | 368 | 2014 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 361 | 2022 |
| Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis MP Sormani, DL Arnold, N De Stefano Annals of neurology 75 (1), 43-49, 2014 | 359 | 2014 |
| Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’(NEDA-4) in relapsing–remitting multiple sclerosis L Kappos, N De Stefano, MS Freedman, BAC Cree, EW Radue, ... Multiple Sclerosis Journal 22 (10), 1297-1305, 2016 | 355 | 2016 |
| Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis N De Stefano, ML Stromillo, A Giorgio, ML Bartolozzi, M Battaglini, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (1), 93-99, 2016 | 345 | 2016 |
| Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis PA Muraro, R Martin, GL Mancardi, R Nicholas, MP Sormani, R Saccardi Nature Reviews Neurology 13 (7), 391-405, 2017 | 328 | 2017 |
| Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial A Brucato, M Imazio, M Gattorno, G Lazaros, S Maestroni, M Carraro, ... Jama 316 (18), 1906-1912, 2016 | 324 | 2016 |
| Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia R Capra, N De Rossi, F Mattioli, G Romanelli, C Scarpazza, MP Sormani, ... European journal of internal medicine 76, 31-35, 2020 | 323 | 2020 |
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Email verificata su unisi.it